https://www.selleckchem.com/pr....oducts/zilurgisertib
atory biomarkers are being investigated including tumor-infiltrating lymphocytes, immune profiling (e.g., effector T cells or regulatory T cells), epigenetic signatures, T-cell receptor repertoire, proteomics, microbiome, and metabolomics.BACKGROUND To evaluate the long-term efficacy and toxicity of radiation therapy in patients with Stage IE primary ocular adnexal mucosa-associated lymphoid tissue lymphoma. METHODS We designed a retrospective analysis to evaluate 81 patients with ocular adnexal mucosa-associated lymphoid
Like
Comment
Share
